A detailed history of Groupama Asset Managment transactions in Abb Vie Inc. stock. As of the latest transaction made, Groupama Asset Managment holds 96,775 shares of ABBV stock, worth $19.4 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
96,775
Previous 83,953 15.27%
Holding current value
$19.4 Million
Previous $15.6 Billion 6.14%
% of portfolio
0.23%
Previous 0.28%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $1.98 Million - $2.32 Million
12,822 Added 15.27%
96,775 $16.6 Billion
Q1 2024

May 14, 2024

SELL
$159.82 - $182.1 $575,352 - $655,560
-3,600 Reduced 4.11%
83,953 $15.6 Billion
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $12 Million - $13.6 Million
87,553 New
87,553 $13.6 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $354B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Groupama Asset Managment Portfolio

Follow Groupama Asset Managment and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Groupama Asset Managment, based on Form 13F filings with the SEC.

News

Stay updated on Groupama Asset Managment with notifications on news.